Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease.

PubWeight™: 1.86‹?› | Rank: Top 3%

🔗 View Article (PMC 3068979)

Published in J Clin Invest on April 01, 2011

Authors

Hans Zischka1, Josef Lichtmannegger, Sabine Schmitt, Nora Jägemann, Sabine Schulz, Daniela Wartini, Luise Jennen, Christian Rust, Nathanael Larochette, Lorenzo Galluzzi, Veronique Chajes, Nathan Bandow, Valérie S Gilles, Alan A DiSpirito, Irene Esposito, Martin Goettlicher, Karl H Summer, Guido Kroemer

Author Affiliations

1: Institute of Toxicology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany. zischka@helmholtz-muenchen.de

Articles citing this

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 1.83

Systems biology of cisplatin resistance: past, present and future. Cell Death Dis (2014) 1.74

Wilson's disease and other neurological copper disorders. Lancet Neurol (2015) 1.53

Methanobactin reverses acute liver failure in a rat model of Wilson disease. J Clin Invest (2016) 1.52

Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology. J Hepatol (2014) 1.05

Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease. Hepatology (2013) 0.89

Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell Cycle (2012) 0.89

Wilson's disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci (2015) 0.87

Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load. PLoS One (2012) 0.86

Copper import into the mitochondrial matrix in Saccharomyces cerevisiae is mediated by Pic2, a mitochondrial carrier family protein. J Biol Chem (2013) 0.85

Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherit Metab Dis (2011) 0.83

Methanobactin and the Link between Copper and Bacterial Methane Oxidation. Microbiol Mol Biol Rev (2016) 0.79

Mitochondrial transplantation attenuates hypoxic pulmonary vasoconstriction. Oncotarget (2016) 0.78

Copper toxicity in Wilson disease explained in a new way. Hepatology (2011) 0.78

Modifying factors and phenotypic diversity in Wilson's disease. Ann N Y Acad Sci (2014) 0.78

Cell therapy to remove excess copper in Wilson's disease. Ann N Y Acad Sci (2014) 0.78

The Features of Copper Metabolism in the Rat Liver during Development. PLoS One (2015) 0.76

Advance in the pathogenesis and treatment of Wilson disease. Transl Neurodegener (2012) 0.76

Mitochondrial Transplantation Attenuates Airway Hyperresponsiveness by Inhibition of Cholinergic Hyperactivity. Theranostics (2016) 0.75

Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients. Front Mol Neurosci (2017) 0.75

Mitochondrial transplantation attenuates hypoxic pulmonary hypertension. Oncotarget (2016) 0.75

An Aminotransferase is Responsible for the Deamination of the N-terminal Leucine and Required for Formation of Oxazolone Ring A in Methanobactin of Methylosinus trichosporium OB3b. Appl Environ Microbiol (2016) 0.75

Methanobactins: from genome to function. Metallomics (2016) 0.75

The Activity of Menkes Disease Protein ATP7A Is Essential for Redox Balance in Mitochondria. J Biol Chem (2016) 0.75

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin. Microb Cell (2014) 0.75

Epithelial magnesium transport by TRPM6 is essential for prenatal development and adult survival. Elife (2016) 0.75

Hepatocellular Carcinoma: An Unusual Complication of Longstanding Wilson Disease. J Clin Exp Hepatol (2016) 0.75

TARGETED INACTIVATION OF COPPER-TRANSPORTER ATP7B IN HEPATOCYTES CAUSES LIVER STEATOSIS AND OBESITY IN MICE. Am J Physiol Gastrointest Liver Physiol (2017) 0.75

Bone demineralisation in a large cohort of Wilson disease patients. J Inherit Metab Dis (2015) 0.75

Articles cited by this

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71

Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70

The pathophysiology of mitochondrial cell death. Science (2004) 13.87

Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72

Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact (2006) 10.64

Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science (1999) 6.86

The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet (1993) 5.97

The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet (1993) 4.70

Mitochondria, oxidative stress and cell death. Apoptosis (2007) 4.29

Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol (2007) 3.90

Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis (1999) 3.71

Penicillamine, a new oral therapy for Wilson's disease. Am J Med (1956) 3.68

Wilson's disease; new oral therapy. Lancet (1956) 3.15

Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver, by S. A. Kinnier Wilson, (From the National Hospital, and the Laboratory of the National Hospital, Queen Square, London) Brain 1912: 34; 295-509. Brain (2009) 2.51

The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem (2003) 2.07

Methanobactin, a copper-acquisition compound from methane-oxidizing bacteria. Science (2004) 1.97

Copper trafficking to the mitochondrion and assembly of copper metalloenzymes. Biochim Biophys Acta (2006) 1.96

Wilson disease. Gastroenterology (2003) 1.93

Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci (2009) 1.85

Glutathionylation of mitochondrial proteins. Antioxid Redox Signal (2005) 1.79

Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix. J Biol Chem (2004) 1.68

The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet (1994) 1.52

The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain (1948) 1.45

Mitochondrial matrix copper complex used in metallation of cytochrome oxidase and superoxide dismutase. J Biol Chem (2006) 1.38

Lipidomic analysis and electron transport chain activities in C57BL/6J mouse brain mitochondria. J Neurochem (2008) 1.29

Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res (2004) 1.29

Metal-induced hepatotoxicity. Semin Liver Dis (1996) 1.29

Fluorescence thiol modification assay: oxidatively modified proteins in Bacillus subtilis. Mol Microbiol (2005) 1.23

NMR, mass spectrometry and chemical evidence reveal a different chemical structure for methanobactin that contains oxazolone rings. J Am Chem Soc (2008) 1.19

Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology (1994) 1.14

Oxidative-phosphorylation defects in liver of patients with Wilson's disease. Lancet (2000) 1.11

Mechanism of copper-catalyzed autoxidation of cysteine. Free Radic Res (1999) 1.11

Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology (1968) 1.07

Mitochondrial structure and function in the untreated Jackson toxic milk (tx-j) mouse, a model for Wilson disease. Mol Genet Metab (2007) 1.03

Liver copper storage and transport during development: implications for cytotoxicity. Am J Clin Nutr (1996) 1.00

Electrophoretic analysis of the mitochondrial outer membrane rupture induced by permeability transition. Anal Chem (2008) 0.99

Diagnosis and treatment of Wilson's disease. Pediatr Transplant (2002) 0.99

Quantitation of mitochondrial transmembrane potential in cells and in isolated mitochondria. Methods Enzymol (2000) 0.99

Isolation of methanobactin from the spent media of methane-oxidizing bacteria. Methods Enzymol (2011) 0.98

Mechanism of production of hydroxyl radicals in the copper-catalyzed oxidation of dithiothreitol. Radiat Res (1997) 0.98

Mechanism of copper-catalyzed oxidation of glutathione. Free Radic Res (1998) 0.95

A new strain of rat for functional analysis of PINA. Brain Res Mol Brain Res (2005) 0.95

Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency. Gastroenterology (1990) 0.92

Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in Long-Evans Cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation. Carcinogenesis (2005) 0.92

Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology (1997) 0.91

Free copper ions in the cell? Science (1999) 0.91

Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease. Hepatology (1992) 0.90

D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism. Hepatology (1992) 0.90

An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats. Hepatology (1995) 0.87

Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. Gastroenterology (1993) 0.86

Long-term storage of mitochondria to preserve energy-linked functions. Methods Enzymol (1979) 0.82

Isolation of highly pure rat liver mitochondria with the aid of zone-electrophoresis in a free flow device (ZE-FFE). Methods Mol Biol (2008) 0.82

Wilson's disease. Clin Liver Dis (2000) 0.81

16-BAC/SDS-PAGE analysis of membrane proteins of yeast mitochondria purified by free flow electrophoresis. Methods Mol Biol (2009) 0.78

Electron microscopy of mitochondria and peroxisomes of human hepatocytes. Prog Liver Dis (1979) 0.78

Articles by these authors

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47

The hallmarks of aging. Cell (2013) 14.29

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

The pathophysiology of mitochondrial cell death. Science (2004) 13.87

Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72

Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2006) 10.54

Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol (2005) 10.27

Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol (2010) 9.06

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73

Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61

Immunogenic cell death in cancer therapy. Annu Rev Immunol (2012) 6.59

Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13

Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov (2006) 5.99

Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97

Autophagy and aging. Cell (2011) 5.96

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (2011) 5.62

Cytoplasmic functions of the tumour suppressor p53. Nature (2009) 5.23

Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 5.00

Cell death by mitotic catastrophe: a molecular definition. Oncogene (2004) 4.75

Cell death by necrosis: towards a molecular definition. Trends Biochem Sci (2006) 4.67

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy (2008) 4.42

An immunosurveillance mechanism controls cancer cell ploidy. Science (2012) 4.35

Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 4.34

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 4.32

Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07

The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 4.01

The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci (2005) 3.93

Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82

Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (2011) 3.74

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity (2013) 3.73

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med (2005) 3.64

Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med (2007) 3.61

The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov (2012) 3.60

Decoding cell death signals in inflammation and immunity. Cell (2010) 3.41

Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol (2011) 3.41

Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol (2011) 3.40

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

Does autophagy contribute to cell death? Autophagy (2005) 3.21

A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med (2006) 3.21

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle (2006) 3.21

AIF deficiency compromises oxidative phosphorylation. EMBO J (2004) 3.19

BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy (2007) 3.08

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med (2011) 3.03

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96

Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle (2009) 2.72

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J (2009) 2.72

Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell (2013) 2.64

Platelet formation is the consequence of caspase activation within megakaryocytes. Blood (2002) 2.62

Necroptosis: a specialized pathway of programmed necrosis. Cell (2008) 2.61

Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med (2003) 2.56

Autophagy regulation by p53. Curr Opin Cell Biol (2010) 2.56

Can autophagy promote longevity? Nat Cell Biol (2010) 2.55

Cell death assays for drug discovery. Nat Rev Drug Discov (2011) 2.51

Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol (2002) 2.47

Methanotrophs and copper. FEMS Microbiol Rev (2010) 2.42

The IKK complex contributes to the induction of autophagy. EMBO J (2009) 2.41

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology (2012) 2.39

Fatty acids trigger mitochondrion-dependent necrosis. Cell Cycle (2010) 2.37

Complex inhibitory effects of nitric oxide on autophagy. Mol Cell (2011) 2.36

An AIF orthologue regulates apoptosis in yeast. J Cell Biol (2004) 2.33

Metabolic targets for cancer therapy. Nat Rev Drug Discov (2013) 2.32

Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res (2010) 2.29

Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol (2012) 2.28

miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res (2010) 2.24

Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol (2011) 2.23

Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21

Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell (2007) 2.20

Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology (2010) 2.18

BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell (2008) 2.17

Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res (2011) 2.16

Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology (2007) 2.15

Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell (2012) 2.14

Alternative cell death mechanisms in development and beyond. Genes Dev (2010) 2.14

Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene (2003) 2.09

Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell Cycle (2010) 2.08